17q23.3 de novo microdeletion involving only TANC2 gene: A new case

Eur J Med Genet. 2020 Dec;63(12):104094. doi: 10.1016/j.ejmg.2020.104094. Epub 2020 Nov 4.

Abstract

Neurodevelopmental disorders (NDDs) show a wide range of overlapping clinical features. Intellectual disability (ID), developmental delay (DD), autism spectrum disorder (ASD), attention-deficit hyperactivity disorder (ADHD), language and communication disorders with or without motor abnormalities and/or epilepsy have been reported associated to single or multiple genes but in many cases the genetic basis remains unknown. The increasingly use of array-CGH has significantly improved the yield of diagnosing genomic disorders and led to the identification of several novel microdeletion and microduplication syndromes. TANC2 encodes a synaptic scaffold protein interacting with multiple neuropsychiatric disorder-related postsynaptic density (PSD) proteins in dendrites. Here, we describe a new case of TANC2 gene disruption in a 17q23.3 de novo microdeletion identified by array-CGH. The patient presented craniofacial dysmorphic features, hypotonia, and severe cognitive and motor impairment. In conclusion, our data add a further line of evidence supporting the role of TANC2 in NDDs and will help further researches to elucidate the regulatory mechanism of synaptic function and plasticity related to TANC2 haploinsufficiency.

Keywords: 17q23.3 microdeletion; Array-CGH; Craniofacial dysmorphic features; Intellectual disability; TANC2 gene.

Publication types

  • Case Reports

MeSH terms

  • Child
  • Chromosome Deletion
  • Chromosomes, Human, Pair 17 / genetics
  • Developmental Disabilities / genetics*
  • Developmental Disabilities / pathology
  • Haploinsufficiency
  • Humans
  • Male
  • Proteins / genetics*

Substances

  • Proteins
  • TANC2 protein, human

Supplementary concepts

  • Chromosome 17, deletion 17q23 q24